-
-
-
-
-
-
-
Tectonic Therapeutics Inc. (TECX) PT Lowered to $60 at Leerink Partners
-
-
-
-
-
-
-
FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
-
-
-
-
-
-
-
Tectonic Therapeutic (TECX) Misses Q4 EPS by 84c
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Tectonic Therapeutics Inc. (TECX)
-
-
-
-
-
-
-
Tectonic Therapeutic (TECX) Files for 2.97M Share Offering by Selling Stockholders
-
443,890 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

